113 related articles for article (PubMed ID: 27506587)
1. Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness.
Fang S; Vaysse A; Brossard M; Wang Y; Deng D; Liu Q; Zhang P; Xu K; Li M; Feng R; Liu H; Dang Y; Chen W; Prieto V; Gershenwald JE; Ross MI; Matejka B; Malke J; Haydu LE; Reveille JD; Sui D; Bassett RL; Koshkina N; Avril MF; Lu M; Wei Q; Demenais F; Amos CI; Lee JE
J Invest Dermatol; 2017 Jan; 137(1):253-257. PubMed ID: 27506587
[No Abstract] [Full Text] [Related]
2. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival.
Dai W; Liu H; Chen K; Xu X; Qian D; Luo S; Amos CI; Lee JE; Li X; Nan H; Li C; Wei Q
Mol Carcinog; 2020 Jun; 59(6):640-650. PubMed ID: 32232919
[TBL] [Abstract][Full Text] [Related]
3. The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health Study.
Cadby G; Ward SV; Cole JM; Moses EK; Millward M; Palmer LJ
Br J Dermatol; 2014 Apr; 170(4):851-7. PubMed ID: 24405011
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.
Li B; Wang Y; Xu Y; Liu H; Bloomer W; Zhu D; Amos CI; Fang S; Lee JE; Li X; Han J; Wei Q
Int J Cancer; 2018 Jun; 142(11):2303-2312. PubMed ID: 29313974
[TBL] [Abstract][Full Text] [Related]
5. The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.
Vogelsang M; Martinez CN; Rendleman J; Bapodra A; Malecek K; Romanchuk A; Kazlow E; Shapiro RL; Berman RS; Krogsgaard M; Osman I; Kirchhoff T
Clin Cancer Res; 2016 Jul; 22(13):3268-80. PubMed ID: 26733611
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
8. The susceptibility CDKN2 locus may have a role on prognosis of melanoma patients.
Casula M; Budroni M; Cossu A; Ascierto PA; Mozzillo N; Canzanella S; Muggiano A; Palmieri G
Ann Oncol; 2010 Jun; 21(6):1379-1380. PubMed ID: 20231302
[No Abstract] [Full Text] [Related]
9. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
10. Genes Determining Nevus Count and Dermoscopic Appearance in Australian Melanoma Cases and Controls.
Duffy DL; Jagirdar K; Lee KJ; McWhirter SR; McMeniman EK; De'Ambrosis B; Pflugfelder A; Rayner JE; Whiteman DC; Brown MA; Martin NG; Smithers BM; Schaider H; Soyer HP; Sturm RA
J Invest Dermatol; 2020 Feb; 140(2):498-501.e17. PubMed ID: 31421127
[No Abstract] [Full Text] [Related]
11. Inherited genetic variants associated with occurrence of multiple primary melanoma.
Gibbs DC; Orlow I; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):992-7. PubMed ID: 25837821
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations identified by whole-exome sequencing in acral melanoma.
Lim Y; Yoon D; Lee DY
J Am Acad Dermatol; 2020 Dec; 83(6):1792-1794. PubMed ID: 32278801
[No Abstract] [Full Text] [Related]
13. Recurrent inactivating RASA2 mutations in melanoma.
Arafeh R; Qutob N; Emmanuel R; Keren-Paz A; Madore J; Elkahloun A; Wilmott JS; Gartner JJ; Di Pizio A; Winograd-Katz S; Sindiri S; Rotkopf R; Dutton-Regester K; Johansson P; Pritchard AL; Waddell N; Hill VK; Lin JC; Hevroni Y; Rosenberg SA; Khan J; Ben-Dor S; Niv MY; Ulitsky I; Mann GJ; Scolyer RA; Hayward NK; Samuels Y
Nat Genet; 2015 Dec; 47(12):1408-10. PubMed ID: 26502337
[TBL] [Abstract][Full Text] [Related]
14. Identification of key genes and pathways for melanoma in the TRIM family.
Xia Y; Zhao J; Yang C
Cancer Med; 2020 Dec; 9(23):8989-9005. PubMed ID: 33118318
[TBL] [Abstract][Full Text] [Related]
15. The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma.
Okamoto I; Roka F; Krögler J; Endler G; Kaufmann S; Tockner S; Marsik C; Jilma B; Mannhalter C; Wagner O; Pehamberger H
J Invest Dermatol; 2006 Oct; 126(10):2242-6. PubMed ID: 16691190
[TBL] [Abstract][Full Text] [Related]
16. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.
Hsueh EC; DeBloom JR; Lee J; Sussman JJ; Covington KR; Middlebrook B; Johnson C; Cook RW; Slingluff CL; McMasters KM
J Hematol Oncol; 2017 Aug; 10(1):152. PubMed ID: 28851416
[TBL] [Abstract][Full Text] [Related]
17. Use of oncogene expression as an independent prognostic marker for primary melanoma.
Grover R; Pacifico MD; Wilson GD; Sanders R
Ann Plast Surg; 2003 Feb; 50(2):183-7. PubMed ID: 12567057
[TBL] [Abstract][Full Text] [Related]
18. No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival.
Luo L; Orlow I; Kanetsky PA; Thomas NE; Fang S; Lee JE; Berwick M; Lee JH;
PLoS One; 2017; 12(3):e0174234. PubMed ID: 28323902
[TBL] [Abstract][Full Text] [Related]
19. Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics.
Gorlov I; Orlow I; Ringelberg C; Hernando E; Ernstoff MS; Cheng C; Her S; Parker JS; Thompson CL; Gerstenblith MR; Berwick M; Amos C
Melanoma Res; 2018 Oct; 28(5):380-389. PubMed ID: 29975213
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival.
Li H; Wang Y; Liu H; Shi Q; Xu Y; Wu W; Zhu D; Amos CI; Fang S; Lee JE; Han J; Wei Q
Int J Cancer; 2017 Mar; 140(6):1270-1279. PubMed ID: 27914105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
